<qa>  What is the non-treatment study of acceptance rates of HSV-1 and HSV-2 typeThis is a non-treatment study of acceptance rates of HSV-1 and HSV-2 type specific serologic testing by pregnant women and their partners. This study will also evaluate Health Care Provider time spent in counseling, effectiveness of counseling toolssessions, and acceptance of antiviral suppression by pregnant women andor their partners. In addition, HSV-2 seroprevalence will be assessed. This study will be conducted at a single center Obstetrics and Gynecology Office and is not designed to yield nationally representative estimates of HSV-2 seroprevalence rates. 